PliuForCaf (dry extract of ivy leaves) capsules 52.5 mg. №30

$10.50

PliuForCaf pharmaceutical product is used for acute inflammatory diseases of the respiratory tract, which are accompanied by a cough.
Also, the PliuForCaf remedy is indicated for symptomatic therapy in patients with chronic inflammatory diseases of the bronchi.

Out of stock

Category:

Description

PliuForCaf Composition and form of release
The active component of this pharmaceutical is an extract of dry leaves of common ivy.
The drug is produced in the form of capsules.

Pharmacological properties
A pharmaceutical product of herbal origin.
This preparation contains dry ivy leaf extract, which has expectorant, antimicrobial, antitussive, anti-inflammatory and antispasmodic effects, which are due to the presence of glycosides (saponins) in it. This pharmaceutical agent helps to reduce the viscosity of sputum and helps to facilitate its discharge.

Indications
PliuForCaf pharmaceutical product is used for acute inflammatory diseases of the respiratory tract, which are accompanied by a cough.
Also, the PliuForCaf remedy is indicated for symptomatic therapy in patients with chronic inflammatory diseases of the bronchi.

Contraindications
It is forbidden to use the drug in patients with hypersensitivity to it, as well as to plants of the Araliaceae family (araliaceae).
Children under twelve years old should not use this pharmaceutical product.
The drug is used with caution in patients with gastric ulcer, gastritis.
Without consulting a doctor, it is not recommended to simultaneously use the drug and antitussive medicines containing dexmetorphan or codeine.

Children
Not applicable to children under 12 years of age.

Application during pregnancy and lactation
Due to the lack of sufficient clinical data, this pharmaceutical is not recommended for women during the above periods.

Method of administration and dosage
Take one PliuForCaf capsule three times a day.
The duration of therapy with this drug is determined by the attending doctor in each clinical case individually. In normal cases, the duration of therapy with this drug is one week. In order to achieve a stable therapeutic effect, treatment with this pharmaceutical preparation should be continued for another two to three days after the improvement of the clinical condition.
If there is no improvement in the condition, it is necessary to contact your doctor as soon as possible for advice on further treatment tactics.
The pharmaceutical product Pluforkaf is allowed to be used in combination with other drugs.

Overdose
Taking the drug in high doses, significantly exceeding the recommended ones, can provoke the development of diarrhea, vomiting, nausea and agitation.
In case of an overdose of PliuForCaf in the first four hours, it is indicated to perform a gastric lavage and give the patient enterosorbents. The following shows symptomatic treatment.

Side effects
The development of allergic reactions against the background of the use of the drug is possible (including skin rashes, suffocation, flushing (redness) of the skin, itching, urticaria, angioedema).
Side effects such as digestive disorders (nausea, abdominal pain, vomiting, diarrhea) can also occur.
If any undesirable phenomena occur during therapy with a pharmaceutical, it is necessary to stop its further use and immediately seek advice from your doctor.

Storage conditions and periods
Store PliuForCaf capsules in their original packaging.
The recommended storage temperature for this pharmaceutical product is below + 25 ° C.
It is required to protect the product in places inaccessible to the child.
The shelf life of this pharmaceutical product is two years. Do not use PliuForCaf capsules after the expiration date printed on the packaging.